John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$254M |
| 2 |
Bank of America
BAC
|
+$228M |
| 3 |
KLA
KLAC
|
+$205M |
| 4 |
TSMC
TSM
|
+$191M |
| 5 |
CVS Health
CVS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Goldman Sachs
GS
|
+$237M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
PayPal
PYPL
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.63% |
| 2 | Healthcare | 13.66% |
| 3 | Financials | 12.92% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXON
451
PUT
Axon Enterprise
AXON
$51B
| $21.1M | 0.05% |
52,700
| – | – |
|
452
BioMarin Pharmaceuticals
BMRN
$12.9B
| $21.1M | 0.05% |
299,531
-40,919
| -12% | -$3.42M |
|
453
Duke Energy
DUK
$93.4B
| $21M | 0.05% |
182,371
-164,504
| -47% | -$18.3M |
|
454
Voya Financial
VOYA
$8.86B
| $20.9M | 0.05% |
263,898
-31,768
| -11% | -$2.27M |
|
455
iShares TIPS Bond ETF
TIP
$14.9B
| $20.8M | 0.05% |
+188,400
| New | +$20.5M |
|
456
PUT
Akamai
AKAM
$15.9B
| $20.8M | 0.05% |
205,600
+10,100
| +5% | +$984K |
|
457
Canadian Imperial Bank of Commerce
CM
$106B
| $20.7M | 0.05% |
+337,488
| New | +$18.3M |
|
458
Weibo
WB
$1.73B
| $20.7M | 0.05% |
2,053,237
+82,816
| +4% | +$652K |
|
459
AB InBev
BUD
$155B
| $20.7M | 0.05% |
311,841
-16,904
| -5% | -$1.04M |
|
|
WBA
460
DELISTED
Walgreens Boots Alliance
WBA
| $20.5M | 0.04% |
+2,283,701
| New | +$23.5M |
|
461
Paycom
PAYC
$10.3B
| $20.4M | 0.04% |
122,724
-92,084
| -43% | -$14.7M |
|
462
Synopsys
SNPS
$76.2B
| $20.4M | 0.04% |
40,213
-48,522
| -55% | -$26M |
|
463
Huntsman Corp
HUN
$1.75B
| $20.2M | 0.04% |
835,154
-377,723
| -31% | -$8.38M |
|
|
NTST
464
NETSTREIT Corp
NTST
$2.07B
| $20.2M | 0.04% |
1,222,229
+616,453
| +102% | +$10.2M |
|
465
Intellia Therapeutics
NTLA
$1.8B
| $20.1M | 0.04% |
980,380
+151,095
| +18% | +$3.48M |
|
466
AtriCure
ATRC
$2.49B
| $20.1M | 0.04% |
717,784
+74,754
| +12% | +$1.84M |
|
467
Under Armour
UAA
$2.32B
| $20.1M | 0.04% |
2,253,174
+2,072,174
| +1,145% | +$15.4M |
|
468
Barclays
BCS
$90.2B
| $20M | 0.04% |
1,648,236
-261,949
| -14% | -$3.07M |
|
469
Strategy Inc
MSTR
$47.4B
| $20M | 0.04% |
+118,504
| New | +$16.9M |
|
470
BJs Wholesale Club
BJ
$12.3B
| $19.9M | 0.04% |
241,562
-332,969
| -58% | -$28.2M |
|
471
Capital One
COF
$134B
| $19.9M | 0.04% |
132,931
-53,646
| -29% | -$7.64M |
|
472
Galicia Financial Group
GGAL
$6.66B
| $19.8M | 0.04% |
469,526
+384,142
| +450% | +$13.4M |
|
473
Evercore
EVR
$11.2B
| $19.8M | 0.04% |
77,979
+34,351
| +79% | +$8.18M |
|
474
Equitable Holdings
EQH
$13.3B
| $19.7M | 0.04% |
467,646
-108,164
| -19% | -$4.44M |
|
475
Deckers Outdoor
DECK
$12.5B
| $19.7M | 0.04% |
123,248
-62,230
| -34% | -$9.49M |
|
Similar funds
John Overdeck's Q3 2024 Portfolio in Review
As of Q3 2024, John Overdeck held 3,433 positions worth $45.6B, up 3.9% from $43.9B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.
John Overdeck withdrew a net $1.83B in Q3 2024, closing 348 positions and reducing 1,306 holdings. Its most notable exit was Intel, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Bank of America worth $226M.
- John Overdeck's largest Q3 2024 buy was Bank of America: 5,683,991 shares worth $226M.
- John Overdeck added most to Alphabet (Google) Class A in Q3 2024, an estimated $254M increase.
- John Overdeck's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.06B.
- John Overdeck fully exited Intel in Q3 2024, selling an estimated $161M.
- John Overdeck's ten largest holdings make up 6.6% of its $45.6B portfolio in Q3 2024.
- John Overdeck opened 444 new positions and closed 348 in Q3 2024.
- John Overdeck's portfolio value rose 3.9% quarter-over-quarter to $45.6B.
Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.